9781573318549 - advances against aspergillosis i: medical science, volume 1272 (annals of the new york academy of sciences, band 1272) (13 Ergebnisse)
- Weitere Bilder
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Softcover
Anbieter: GreatBookPrices, Columbia, MD, USAGreatBookPrices
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 73,49
EUR 2,29 VersandVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Zustand: New.
- Softcover
Anbieter: INDOO, Avenel, NJ, USAINDOO
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 75,86
Versand gratisVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Zustand: New.
- Softcover
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes KönigreichPhatpocket Limited
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 74,64
EUR 12,44 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Zustand: Like New. Used - Like New. Book is new and unread but may have minor shelf wear. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
- Weitere Bilder
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Softcover
Anbieter: GreatBookPrices, Columbia, MD, USAGreatBookPrices
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 86,55
EUR 2,29 VersandVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Zustand: As New. Unread book in perfect condition.
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Softcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 77,93
EUR 17,54 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Zustand: As New. Unread book in perfect condition.
- Softcover
- Erstausgabe
Anbieter: Grand Eagle Retail, Bensenville, IL, USAGrand Eagle Retail
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 99,12
Versand gratisVersand innerhalb von USAAnzahl: 1 verfügbar
Paperback. Zustand: new. Paperback. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challengeparticularly in the face of increasing antifungal resistance. Bringing together the worlds leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary… collaboration among clinicians, industry, and scientific experts, the Advances Against Aspergillosis conference was held January 2628, 2012 in Istanbul, Turkey. This first of two Annals volumes contains short reviews encapsulating recent clinical findings on aspergillosis. Among the topics included are the application of diagnostic markers to invasive aspergillosis in children, risk stratification for invasive aspergillosis in immunocompromised patients, use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis, immune regulation in idiopathic bronchiectasis, and management of chronic pulmonary aspergillosis. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Softcover
- Erstausgabe
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandKennys Bookshop and Art Galleries Ltd.
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 106,09
EUR 9,50 VersandVersand von Irland nach USAAnzahl: 15 verfügbar
Zustand: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pages…: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . .
- Softcover
Anbieter: Ubiquity Trade, Miami, FL, USAUbiquity Trade
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Neu
EUR 115,34
EUR 2,60 VersandVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Zustand: New. Brand new! Please provide a physical shipping address.
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Softcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 114,61
EUR 17,54 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Zustand: New.
- Softcover
Anbieter: Kennys Bookstore, Olney, MD, USAKennys Bookstore
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 131,60
EUR 9,10 VersandVersand innerhalb von USAAnzahl: 15 verfügbar
Zustand: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pages…: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
- Weitere Bilder
- Softcover
Anbieter: moluna, Greven, Deutschlandmoluna
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 104,32
EUR 48,99 VersandVersand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.KlappentextAspergillosis, the leading fungal ca.
- Softcover
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes KönigreichMispah books
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Wie neu
EUR 144,49
EUR 29,23 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Paperback. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Softcover
- Erstausgabe
Anbieter: AussieBookSeller, Truganina, VIC, AustralienAussieBookSeller
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 152,71
EUR 32,08 VersandVersand von Australien nach USAAnzahl: 1 verfügbar
Paperback. Zustand: new. Paperback. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challengeparticularly in the face of increasing antifungal resistance. Bringing together the worlds leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary… collaboration among clinicians, industry, and scientific experts, the Advances Against Aspergillosis conference was held January 2628, 2012 in Istanbul, Turkey. This first of two Annals volumes contains short reviews encapsulating recent clinical findings on aspergillosis. Among the topics included are the application of diagnostic markers to invasive aspergillosis in children, risk stratification for invasive aspergillosis in immunocompromised patients, use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis, immune regulation in idiopathic bronchiectasis, and management of chronic pulmonary aspergillosis. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
